Skip to content

The effect of Fospropofol Disodium on postoperative delirium and early recovery quality in elderly patients with abdominal tumors: a multicenter randomized controlled trial

The effect of Fospropofol Disodium on postoperative delirium and early recovery quality in elderly patients with abdominal tumors: a multicenter randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119084
Enrollment
Unknown
Registered
2026-02-14
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Fospropofol Disodium Group:Fospropofol Disodium intravenous anesthesia maintenance
Sevoflurane Group:Sevoflurane inhalation anesthesia maintenance

Sponsors

chongqing university cancer hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 60-80 years old, gender not limited; 2.American Society of Anesthesiologists (ASA): Grade II-III; 3.Body Mass Index (BMI): >=18.5 kg/m^2 and=2h,&<=5h; 5.Voluntarily participated and signed an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Individuals with contraindications to general anesthesia or a history of anesthesia accidents; 2.Patients with combined traumatic brain injury, intracranial hypertension, stroke, unstable angina, and myocardial infarction; 3. Respiratory insufficiency, acute phase of obstructive pulmonary disease, presence of difficult airways, or difficulty in endotracheal intubation (modified Mahalanobis score III-IV); 4.Uncontrolled diabetes or hypertension; 5.History of drug use, alcohol abuse, or drug dependence; 6.Abuse or long-term use of anesthetics, sedatives, and analgesics; 7. Individuals who are known or suspected to be allergic or contraindicated to the various components of the investigational drug or the standardized use of drugs specified in the protocol (such as sufentanil citrate injection, propofol, remifentanil hydrochloride injection, and propofol disodium injection); 8.Individuals with a history of mental illness or preoperative cognitive impairment; 9. Individuals who have participated in any drug clinical trials within the past month prior to screening; 10. The researchers believe that there are any other factors that are not suitable for participants in this experiment.

Design outcomes

Primary

MeasureTime frame
postoperative delirium;

Secondary

MeasureTime frame
postoperative recovery quality;hemodynamics;Complications during the anesthesia recovery period;pain score;

Countries

China

Contacts

Public ContactQianyun Pang

chongqing university cancer hospital

pqy047417@163.com+86 23 65075689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026